Diabetes Devices Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2024-2032

Growth Factors of Diabetes Devices Market

The global diabetes devices market size was valued at USD 20.92 billion in 2018 and is projected tgrow tUSD 48.35 billion by 2032, exhibiting a CAGR of 6.3% during the forecast period of 2019-2032.

The COVID-19 pandemic disrupted delivery chains but improved the decision for diabetes gadgets like glucose videshow devices and insulin pumps, pushing through the need for far-flung healthcare management and impeding the diabetes devices market growth.

The diabetes gadgets marketplace is pushed by the developing incidence of diabetes, developing health consciousness, technological improvements in glucose tracking and insulin shipping systems, and increasing demand for minimally invasive answers timprove affected person results.

The diabetes gadgets marketplace is experiencing a full-size boom, pushed by the rising occurrence of diabetes globally and improvements in the medical era. Key trends consist of the growing adoption of non-stop glucose tracking (CGM) structures, the improvement of extra accurate and person-friendly insulin delivery devices, and the integration of artificial intelligence (AI) and gadget mastering (ML) for personalized diabetes control, leading tthe expansion of diabetes devices market share globally.

Comprehensive Analysis of Diabetes Devices Market

The diabetes gadgets market is segmented through kind and distribution channels. Based on kind, the marketplace includes monitoring and treatment gadgets, with tracking devices protecting the essential proportion due tadvancements in continuous glucose monitoring systems, smart insulin pumps, and wearable technology that decorate self-diabetes control. By distribution channel, the market is divided intinstitutional and retail sales, with retail income mainly due tthe developing availability of private-label manufacturers at discounted charges and extended adoption of diabetes care merchandise in shops. Institutional sales are alsexpected tdevelop, pushed by the growing desire for blood glucose tracking through surgical procedures and chronic ailment management.

The Asia Pacific region led the diabetes devices market by benefitting a size of USD 8.48 billion in 2018 due tthe growing diabetes populace and the fairly decreased charges of insulin and insulin transport devices.

The leading players in the diabetes devices market significantly influence its growth trajectory and set industry standards. These key players, including F. Hoffmann-La Roche Ltd (Switzerland), Tandem Diabetes Care, Inc. (U.S.), B. Braun Melsungen AG (Germany), Medtronic (Ireland), BD (U.S.), NovNordisk A/S (Denmark), Abbott (U.S.), Sanofi (France), and other prominent companies, contribute ta competitive landscape, driving innovation and market advancement in diabetes care technology.

In May 2021, Medtronic introduced that it had acquired European acclaim for diabetes control devices. The first is InPen, a related insulin pen intended for those requiring a couple of daily injections. The second is the Guardian 4 sensor, which can be used either as a standalone non-stop glucose reveal or along with InPen, and each gadget is CE-marked.

Segmentation Table

ATTRIBUTE DETAILS

Study Period 2015-2026

Base Year 2018

Forecast Period 2019-2026

Historical Period 2015-2017

Unit Value (USD billion)

Segmentation By Type

Blood Glucose Monitoring Systems

Continuous Glucose Monitoring Systems

Self-Monitoring Blood Glucose Systems

Treatment Devices

Insulin Pens

Insulin Pumps

Insulin Jet Injectors

Insulin Syringes

Others

By Distribution Channel

Institutional Sales

Retail Sales

By Geography

North America (U.S. and Canada)

Europe (U.K., Germany, France, Italy, Spain, Scandinavia, and Rest of Europe)

Asia Pacific (Japan, China, India, Australia, Southeast Asia, and Rest of Asia Pacific)

Latin America (Brazil, Mexico, and Rest of Latin America)

Middle East & Africa (South Africa, GCC and Rest of Middle East & Africa)


1. Introduction
1.1. Research Scope
1.2. Market Segmentation
1.3. Research Methodology
1.4. Definitions and Assumptions
2. Executive Summary
3. Market Dynamics
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
4. Key Insights
4.1. Prevalence and Incidence of Diabetes by Key Countries
4.2. Technological Advancements
4.3. Pricing Analysis, by Key Market Players/ Key Regions
4.4. Recent Industry Developments Such As Mergers & Acquisitions
5. Global Diabetes Devices Market Analysis, Insights and Forecast, 2015-2026
5.1. Key Findings / Summary
5.2. Market Analysis, Insights and Forecast– By Type
5.2.1. Blood Glucose Monitoring Systems
5.2.1.1. Continuous Glucose Monitoring Systems
5.2.1.2. Self-Monitoring Blood Glucose Systems
5.2.2. Treatment Devices
5.2.2.1. Insulin Pens
5.2.2.2. Insulin Pumps
5.2.2.3. Insulin Jet Injectors
5.2.2.4. Insulin Syringes
5.2.2.5. Others
5.3. Market Analysis, Insights and Forecast– By Distribution Channel
5.3.1. Institutional Sales
5.3.2. Retail Sales
5.4. Market Analysis, Insights and Forecast– By Region
5.4.1. North America
5.4.2. Europe
5.4.3. Asia Pacific
5.4.4. Latin America
5.4.5. Middle East & Africa
6. North America Diabetes Devices Market Analysis, Insights and Forecast, 2015-2026
6.1. Key Findings / Summary
6.2. Market Analysis, Insights and Forecast – By Type
6.2.1. Blood Glucose Monitoring Systems
6.2.1.1. Continuous Glucose Monitoring Systems
6.2.1.2. Self-Monitoring Blood Glucose Systems
6.2.2. Treatment Devices
6.2.2.1. Insulin Pens
6.2.2.2. Insulin Pumps
6.2.2.3. Insulin Jet Injectors
6.2.2.4. Insulin Syringes
6.2.2.5. Others
6.3. Market Analysis, Insights and Forecast – By Distribution Channel
6.3.1. Institutional Sales
6.3.2. Retail Sales
6.4. Market Analysis, Insights and Forecast – By Country
6.4.1. U.S.
6.4.2. Canada
7. Europe Diabetes Devices Market Analysis, Insights and Forecast, 2015-2026
7.1. Key Findings / Summary
7.2. Market Analysis, Insights and Forecast – By Type
7.2.1. Blood Glucose Monitoring Systems
7.2.1.1. Continuous Glucose Monitoring Systems
7.2.1.2. Self-Monitoring Blood Glucose Systems
7.2.2. Treatment Devices
7.2.2.1. Insulin Pens
7.2.2.2. Insulin Pumps
7.2.2.3. Insulin Jet Injectors
7.2.2.4. Insulin Syringes
7.2.2.5. Others
7.3. Market Analysis, Insights and Forecast – By Distribution Channel
7.3.1. Institutional Sales
7.3.2. Retail Sales
7.4. Market Analysis, Insights and Forecast – By Country/Sub-region
7.4.1. U.K.
7.4.2. Germany
7.4.3. Spain
7.4.4. Italy
7.4.5. Scandinavia
7.4.6. France
7.4.7. Rest of Europe
8. Asia Pacific Diabetes Devices Market Analysis, Insights and Forecast, 2015-2026
8.1. Key Findings / Summary
8.2. Market Analysis, Insights and Forecast – By Type
8.2.1. Blood Glucose Monitoring Systems
8.2.1.1. Continuous Glucose Monitoring Systems
8.2.1.2. Self-Monitoring Blood Glucose Systems
8.2.2. Treatment Devices
8.2.2.1. Insulin Pens
8.2.2.2. Insulin Pumps
8.2.2.3. Insulin Jet Injectors
8.2.2.4. Insulin Syringes
8.2.2.5. Others
8.3. Market Analysis, Insights and Forecast – By Distribution Channel
8.3.1. Institutional Sales
8.3.2. Retail Sales
8.4. Market Analysis, Insights and Forecast – By Country/Sub-region
8.4.1. China
8.4.2. India
8.4.3. Australia
8.4.4. Japan
8.4.5. Southeast Asia
8.4.6. Rest of Asia Pacific
9. Latin America Diabetes Devices Market Analysis, Insights and Forecast, 2015-2026
9.1. Key Findings / Summary
9.2. Market Analysis, Insights and Forecast – By Type
9.2.1. Blood Glucose Monitoring Systems
9.2.1.1. Continuous Glucose Monitoring Systems
9.2.1.2. Self-Monitoring Blood Glucose Systems
9.2.2. Treatment Devices
9.2.2.1. Insulin Pens
9.2.2.2. Insulin Pumps
9.2.2.3. Insulin Jet Injectors
9.2.2.4. Insulin Syringes
9.2.2.5. Others
9.3. Market Analysis, Insights and Forecast – By Distribution Channel
9.3.1. Institutional Sales
9.3.2. Retail Sales
9.4. Market Analysis, Insights and Forecast – By Country/Sub-region
9.4.1. Brazil
9.4.2. Mexico
9.4.3. Rest of Latin America
10. Middle East & Africa Diabetes Devices Market Analysis, Insights and Forecast, 2015-2026
10.1. Key Findings / Summary
10.2. Market Analysis, Insights and Forecast – By Type
10.2.1. Blood Glucose Monitoring Systems
10.2.1.1. Continuous Glucose Monitoring Systems
10.2.1.2. Self-Monitoring Blood Glucose Systems
10.2.2. Treatment Devices
10.2.2.1. Insulin Pens
10.2.2.2. Insulin Pumps
10.2.2.3. Insulin Jet Injectors
10.2.2.4. Insulin Syringes
10.2.2.5. Others
10.3. Market Analysis, Insights and Forecast – By Distribution Channel
10.3.1. Institutional Sales
10.3.2. Retail Sales
10.4. Market Analysis, Insights and Forecast – By Country/Sub-region
10.4.1. South Africa
10.4.2. GCC
10.4.3. Rest of Middle East and Africa
11. Competitive Analysis
11.1. Key Industry Developments
11.2. Global Market Share Analysis (2018)
11.3. Company Profiles
11.3.1. F. Hoffmann-La Roche Ltd.
11.3.1.1. Overview,
11.3.1.2. Types & services,
11.3.1.3. SWOT analysis,
11.3.1.4. Recent developments,
11.3.1.5. strategies,
11.3.1.6. financials (based on availability)
11.3.2. Tandem Diabetes Care, Inc.
11.3.2.1. Overview,
11.3.2.2. Types & services,
11.3.2.3. SWOT analysis,
11.3.2.4. Recent developments,
11.3.2.5. strategies,
11.3.2.6. financials (based on availability)
11.3.3. B. Braun Melsungen AG
11.3.3.1. Overview,
11.3.3.2. Types & services,
11.3.3.3. SWOT analysis,
11.3.3.4. Recent developments,
11.3.3.5. strategies,
11.3.3.6. financials (based on availability)
11.3.4. Medtronic
11.3.4.1. Overview,
11.3.4.2. Types & services,
11.3.4.3. SWOT analysis,
11.3.4.4. Recent developments,
11.3.4.5. strategies,
11.3.4.6. financials (based on availability)
11.3.5. BD
11.3.5.1. Overview,
11.3.5.2. Types & services,
11.3.5.3. SWOT analysis,
11.3.5.4. Recent developments,
11.3.5.5. strategies,
11.3.5.6. financials (based on availability)
11.3.6. Novo Nordisk A/S
11.3.6.1. Overview,
11.3.6.2. Types & services,
11.3.6.3. SWOT analysis,
11.3.6.4. Recent developments,
11.3.6.5. strategies,
11.3.6.6. financials (based on availability)
11.3.7. Abbott
11.3.7.1. Overview,
11.3.7.2. Types & services,
11.3.7.3. SWOT analysis,
11.3.7.4. Recent developments,
11.3.7.5. strategies,
11.3.7.6. financials (based on availability)
11.3.8. Other Prominent Players
11.3.8.1. Overview,
11.3.8.2. Types & services,
11.3.8.3. SWOT analysis,
11.3.8.4. Recent developments,
11.3.8.5. strategies,
11.3.8.6. financials (based on availability)
12. Strategic Recommendations
"

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings